Polymorphisms (rs7336610 and rs1428), haplotype AC (rs4284505-rs1428) and CA (rs7336610-rs4284505) of MIR17HG were correlated with increased multiple myeloma risk, whereas haplotype GC (rs4284505-rs1428) significantly elevated multiple myeloma risk [22]. This evidence concerns the gene MIR17HG and plasma cell myeloma.